Correlation Between Design Therapeutics and Aadi Bioscience
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Aadi Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Aadi Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Aadi Bioscience, you can compare the effects of market volatilities on Design Therapeutics and Aadi Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Aadi Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Aadi Bioscience.
Diversification Opportunities for Design Therapeutics and Aadi Bioscience
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Design and Aadi is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Aadi Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aadi Bioscience and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Aadi Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aadi Bioscience has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Aadi Bioscience go up and down completely randomly.
Pair Corralation between Design Therapeutics and Aadi Bioscience
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.32 times less return on investment than Aadi Bioscience. In addition to that, Design Therapeutics is 1.98 times more volatile than Aadi Bioscience. It trades about 0.08 of its total potential returns per unit of risk. Aadi Bioscience is currently generating about 0.2 per unit of volatility. If you would invest 177.00 in Aadi Bioscience on September 12, 2024 and sell it today you would earn a total of 65.00 from holding Aadi Bioscience or generate 36.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Aadi Bioscience
Performance |
| Timeline |
| Design Therapeutics |
| Aadi Bioscience |
Design Therapeutics and Aadi Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Aadi Bioscience
The main advantage of trading using opposite Design Therapeutics and Aadi Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Aadi Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will offset losses from the drop in Aadi Bioscience's long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| Aadi Bioscience vs. Anebulo Pharmaceuticals | Aadi Bioscience vs. Adagene | Aadi Bioscience vs. Acrivon Therapeutics, Common | Aadi Bioscience vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |